Original Article PLATELET COUNT TO SPLEEN DIAMETER RATIO AS A PREDICTOR OF ESOPHAGEAL VARICES IN PATIENTS OF LIVER CIRRHOSIS DUE TO HEPATITIS C VIRUS

Similar documents
Detection of Esophageal Varices in Liver Cirrhosis Using Non-invasive Parameters

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Evaluation of Clinical, Biochemical and Ultrasound Parameters in Diagnosis of Oesophageal Varices

Doppler Surrogate Endoscopy for Screening Esophageal Varices in Patients With Cirrhosis

Liver failure &portal hypertension

Correlation of Child Pugh Class of Cirrhosis and Lipid Profile

Correlation of serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension in chronic liver disease

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea

Journal of American Science 2014;10(10)

P ortal hypertension commonly accompanies the presence

Corresponding Author: Dr. Ali Saqib, Department of Medicine, Madina Teaching Hospital, Faisalabad.

Sandipan Ghose, Md. Azizul Hoque, Md. Khalilur Rahman, Mohd. Harun-or-Rashid

Non-Endoscopic Predictors of Esophageal Varices and Portal Hypertensive Gastropathy

Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

PORTAL HYPERTENSION An Introduction to the Culprit of Many Liver Failure Complications

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

Module 1 Introduction of hepatitis

Comparison between Combination of Band ligation and Propranolol with Propranolol alone in Secondary Prophylaxis of Variceal bleed

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients

Serag Esmat 1 and Dalia Omran 2

Diagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion

Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients

CHAPTER 1. Alcoholic Liver Disease

GI bleeding in chronic liver disease

Role of Branched Chain Amino Acids in Hepatic Encephalopathy

Non Invasive Diagnosis of Esophageal Varices: Can it Replace Screening Endoscopy?

Assessment of Liver Function: Implications for HCC Treatment

Patterns of abnormal LFTs and their differential diagnosis

JMSCR Vol 05 Issue 11 Page November 2017

Ultrasonographic Triangular Cord Sign and Gallbladder Abnormality in Diagnosis of Biliary Atresia

Gall bladder wall thickening as noninvasive screening parameter for esophageal varices a comparative endoscopic sonographic study

European. Young Hepatologists Workshop. Organized by : Quantification of fibrosis and cirrhosis outcomes

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph

King Abdul-Aziz University Hospital (KAUH) is a tertiary

BETA-BLOCKERS IN CIRRHOSIS.PRO.

Index. Note: Page numbers of article titles are in boldface type.

Capsule Endoscopy: Is it Really Helpful in the Diagnosis of Small Bowel Diseases? Kashif Malik, Muhammad Joher Amin, Syed Waqar Hassan Shah

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem

Surveillance for Hepatocellular Carcinoma

Ultrasound assessment of coronary veins as non-invasive marker for esophageal varices

Michele Bettinelli RN CCRN Lahey Health and Medical Center

Liver Failure. The most severe clinical consequence of liver disease is liver failure:

Hepatitis Alert: Management of Patients With HCV Who Have Achieved SVR

Non-Invasive Testing for Liver Fibrosis

Cyanoacrylate Glue versus Band Ligation for Acute Gastric Variceal Hemorrhage - A randomized controlled trial at Services Hospital, Lahore

Patterns of abnormal LFTs and their differential diagnosis

ORIGINAL ARTICLES LIVER, PANCREAS AND BILIARY TRACT

FREQUENCY OF DIABETIC KETOACIDOSIS IN DIABETIC PATIENTS

Liver Transplantation: The End of the Road in Chronic Hepatitis C Infection

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed?

Detection of Esophageal Varices Using CT and MRI

Severity and Mortality Prediction in Chronic Liver Disease using Child PUGH and MELD scales

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

Title: The Baveno VI criteria for predicting esophageal varices: validation in real life practice

Original Article. Authors

Etiology of liver cirrhosis

Chief infectionist of Kirov region Head of department in Kirov ID Hospital

Screening for Portal Hypertension in Cirrhosis

Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12:

Evidence-Base Management of Esophageal and Gastric Varices

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA

Upper Gastrointestinal Bleeding Score for Differentiating Variceal and Nonvariceal Upper Gastrointestinal Bleeding ABSTRACT

Complications of Cirrhosis

Hepatitis C Virus (HCV)

World Health Organization. Western Pacific Region

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

PORTAL HYPERTENSION. Tianjin Medical University LIU JIAN

Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark

The Value of Renal Artery Resistive Indices: Association with

Original article Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension

CORRELATION OF PORTAL VEIN PULSATILITY PATTERN AND SEVERITY OF LIVER DISEASE IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION

Management of Cirrhotic Patients Undergoing Non-Transplant Surgery

Adrenal Insufficiency in Patients with Liver Cirrhosis and Severe Sepsis: Effect on Survival after Treatment with Hydrocortisone ABSTRACT

Validation of Clinical Outcomes in Electronic Data Sources

LIVER, PANCREAS, AND BILIARY TRACT

Transmission of HCV in the United States (CDC estimate)

326 Barrera F, et al.,, 2009; 8 (4): presence of esophageal varices. These studies have shown that clinical, biochemical and ultrasonographic

Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding Raines D L, Dupont A W, Arguedas M R

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

ENDOSCOPIC LIGATION OF ESOPHAGEAL VARICES LONG TERM RESULTS

LIVER BIOPSY - THE FACTS. Abnormal liver function tests do suggest chronic disease, but there is no

MANAGING END STAGE LIVER DISEASE IN RESOURCE LIMITED SETTINGS

Clinical Trials & Endpoints in NASH Cirrhosis

Beta-blockers in cirrhosis: Cons

Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation

ORIGINAL ARTICLE. Jun Zheng 1, Rong-chun Xing 1, Wei-hong Zheng 2, Wei Liu 1, Ru-cheng Yao 1, Xiao-song Li 1, Jian-ping Du 1, Lin Li 1.

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

PROPOSTA DI UN NUOVO ALGORIMO PER LA DIAGNOSI ECOGRAFICA DELLE MALATTIE CRONICHE DEL FEGATO

Supplemental Appendix. 1. Protocol Definition of Sustained Virologic Response. A patient has a sustained virologic response if:

Update in abdominal Surgery in cirrhotic patients

Hepatitis Panel/Acute Hepatitis Panel

Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis

Systemic Inflammatory Response Syndrome and MELD Score in Hospital Outcome of Patients with Liver Cirrhosis

Faculty Disclosure. Objectives. Cirrhosis Management for the Family Physician 18/11/2014

Alice Fung, MD Oregon Health and Science University

To Assess the Frequency of Different Clinical Presentations in Patients with Living Donor Liver Transplant Anastomotic Biliary Stricture

Transcription:

Original Article AS A PREDICTOR OF ESOPHAGEAL VARICES IN PATIENTS OF LIVER CIRRHOSIS DUE TO HEPATITIS C VIRUS Khalid Amin 1, Dilshad Muhammad 2, Amin Anjum 3, Kashif Jamil 4, Ali Hassan 5 1 Associate Professor of Medicine, Punjab Medical College, Faisalabad. 2 Senior Registrar, DHQ Hospital, Faisalabad. 3 Senior Registrar MU-IV, DHQ Hospital, Faisalabad. 4 Registrar MU-IV, DHQ Hospital, Faisalabad. 5 Registrar MU-IV, DHQ Hospital, Faisalabad. ABSTRACT Objective: This study was carried out to find diagnostic accuracy of platelet count to spleen diameter ratio as a predictor of esophageal varices in patients of liver cirrhosis due to Hepatitis C virus taking upper gastrointestinal tract endoscopy as gold standard. Design: Cross-sectional study. Setting: DHQ Hospital, Faisalabad. Duration of study: Six (6) months from staring from April 01, 2009 to September 30, 2009. Subjects and methods: 95 patients of either sex having cirrhosis of liver secondary to Hepatitis C virus (diagnosed by coarse echo texture with reduced liver span on abdominal ultrasonography and positive polymerase chain reaction for Hepatitis C virus were considered as cirrhotic) were included in the study. All relevant investigations were carried out including upper gastrointestinal tract endoscopy, abdominal ultrasound scan, complete blood count, serum albumin level, serum billirubin level, prothrombin time (PT) and other clinical sign were recorded. Results: Forty seven (49.5%) patients were male and 48 (50.5%) patients were females. Mean platelet count was 133.22+22.83 10 3 /mm 3 of patients who have not developed varices yet and mean platelet count was 97.29+13.47 10 3 /mm 3 of patients who developed varices. Patients with varices had mean spleen diameter of 13.941±1.33 (centimeters) cms and without varices had 11.70±1.23 cms mean spleen diameter. The mean platelet count to spleen diameter ratio of patients without varices was 1162.41±242.43 and that of with varices was 704.28±142.11. Conclusion: Platelet count to spleen diameter ratio (considering >909 as normal) has good diagnostic accuracy in identifying cases with esophageal varices. Keywords: Platelet count, spleen diameter, esophageal varices, platelet count to spleen diameter ratio, diagnostic accuracy Corresponding Author: Dr. Khalid Amin, Associate Professor, Punjab Medical College, Faisalabad. Email: drkamin2002@yahoo.com INTRODUCTION Cirrhosis is end-stage liver disease due to many causes which disrupts normal liver architecture. Cirrhosis results from necrosis of liver cells followed by fibrosis and nodule 6 JUMDC Vol. 3, Issue 1, Jan-Jun 2012

formation. 1 Clinically most patients are asymptomatic or have mild fatigue, and liver synthetic function is usually preserved, others present with advanced liver disease complicated by variceal bleeding, ascites, coagulopathy, or encephalopathy. 2 WHO has estimated that cirrhosis is responsible for 1.1% of all deaths. Cirrhosis is 10 th most common cause of death in USA. 3 In cirrhotic patients development of portal hypertension leads to ascites and its complication, spontaneous bacterial peritonitis and esophageal varices. 4 In portal hypertension if pressure rises above 20 mmhg, collaterals develop. Portal hypertension is caused by a combination of two simultaneously occurring hemodynamic processes: (1) increased intrahepatic resistance to the passage of blood flow through the liver, and (2) increased splanchnic blood flow. Portal hypertension is directly responsible for variceal hemorrhage and ascites. Variceal hemorrhage is an immediate life-threatening problem with a 20 30% mortality. 5 When the cut off value of platelet count/spleen diameter ratio of 909 was used by Giannini E et al. 6 in Genova Italy, to predict the presence of esophageal varices the sensitivity was 100% specificity was 93%. Positive and negative predictive values for a platelet count/spleen diameter ratio <909 were 96% and 100%, respectively. Diagnostic accuracy of this platelet count/spleen diameter ratio with a cut off value of 909 was 98%. Sarwar S et al. 7 at Shaikh Zayed Medical Complex Lahore, found sensitivity and specificity of platelet count/splenic diameter in centimeters ratio to predict esophageal varices with a cut off value of 909 to be 13 and 77%, respectively, which is far from significant. The results of Sarwar S et al. 7 differ from this present study as well as with Giannini E et al. 6. MATERIALS AND METHODS Study design: Cross-sectional study. Study setting: Study was carried out at medical wards of DHQ Hospital, Faisalabad. Duration of study: Six (6) months from April 2009 to September 2009. Data collection procedure: Ninety five patients coming through OPD/ emergency department admitted in medical wards of DHQ Hospital Faisalabad diagnosed as patients of liver cirrhosis due to hepatitis C virus were included in this study. Informed consent was obtained. The variables were taken like age, sex, duration of symptoms, B.P., pulse, Respiratory rate, Temperature, Spleen size, Platelet count, Spleen Diameter in centimeters, Clubbing, Cyanosis, Flapping tremors, palmar erythema and presence of Ascites. The purpose of research was explained to each patient. Each patient underwent ultrasonography (by a radiologist) of abdomen to measure the spleen diameter in centimeters. Each patient underwent endoscopy of upper gastrointestinal tract to find out whether he/she have developed esophageal varices or not. Platelet count of each patient was determined. Data analysis procedure: The data was entered in SPSS version 12 computer program. The descriptive statistics were calculated. The quantitative variables of the study were age, duration of symptoms, B.P., pulse rate, respiratory rate, temperature, spleen size, platelet count, spleen diameter in centimeters and portal vein size. These variables are presented as Mean + SD. The qualitative Variables were sex of the patient, Edema, Clubbing, Cyanosis, Flapping tremors, palmar erythema and presence of Ascites. These variables are presented as percentage. The diagnostic accuracy of platelet count to spleen diameter ratio is determined by applying screening tests i.e. Sensitivity, Specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV) and diagnostic accuracy as shown in the following tables. Endoscopic findings have been taken as Gold Standard. RESULTS OF STUDY Ninety five patients diagnosed to have cirrhosis of liver due to hepatitis C virus were included in this study. The mean age of the patients was 57.61+11.161 years. The maximum patients were 36(38%) in the age range of 51-60 year (Fig. 1). JUMDC Vol. 3, Issue 1, Jan-Jun 2012 7

In this study 47 (49.5%) patients were male and 48(50.5%) patients were females. All patients were categorized according to Child- Turcotte-Pugh classification. 29 patients (30.52%) were in Child-Turcotte-Pugh grade A, 35 patients (36.84%) were in Child- Turcotte-Pugh grade B while 31 patients (32.63%) fell in the category named Child- Turcotte-Pugh grade C. Esophageal endoscopy was performed and it was found that 27 (284%) patients did not develope varices yet. Remaining 68 (71.6%) patients developed varices. Of these sixty eight patients (1.1%) one patient had grade I varices. Grade II varices were found in 20 (21.1%) patients, grade III varices were found in 23 (24.2%) patients and 24 (25.3%) patients had developed grade IV varices (Fig. 2). The mean platelet count to spleen diameter ratio of all the patients was 834.48±271.670. Mean platelet count to spleen diameter ratio of Child-Turcotte-Pugh Grade A category patients was 1137.66±47.797. Child-Turcotte- Pugh Grade B category patients had mean platelet count to spleen diameter ratio of 728.23±26.265. In case of Child-Turcotte- Pugh Grade C category patients mean platelet count to spleen diameter ratio of 670.84±19.970 was observed in the study (Table 1). 8 JUMDC Vol. 3, Issue 1, Jan-Jun 2012

Table 1. Platelet count to spleen diameter ratio of different child-turcottepugh grades (n=95) Child-turcottepugh grade n Mean + SE Grade A 29 1137.66 + 47.797 Grade B 35 728.23 + 26.265 Grade C 31 670.84 + 19.970 The mean platelet count to spleen diameter ratio of patients without varices was 1162.41±46.657 and those of with varices was 704.28±17.234 (Table 2). Considering platelet count/splenic diameter in centimeters ratio >909 as normal and keeping in view the endoscopic findings true positive cases (Table 3) were 61 (64.2%), true negative were 22 (23.2%), false positive were 5 (5.3%) and false negative cases were 7 (7.4%). These values were put in the 2 2 table (Table 4). Calculations were done and the results were that, the sensitivity (also Table 2. Platelet count to spleen diameter ratio according to presence of esophageal varices (n=95) Esophageal varices n Mean + SE No 29 1162.41+46.657 Yes 66 704.28+17.234 Table 3. Distribution of patients according to 2 x 2 table status (n=95) Parameter True False Percentage Positive 61 5 66 Negative 22 7 29 Total 83 12 95 Positive likelihood ratio found to be 4.84 and negative likelihood ratio was 0.12 in this study. Diagnostic Accuracy of platelet count to spleen diameter ratio as a predictor of esophageal varices in patients of liver cirrhosis due to Hepatitis C virus taking upper gastrointestinal tract endoscopy as gold standard is 87.36%. Table 4. Table of 2 x 2 (n=95) Platelet count to spleen diameter ratio (Considering>909 as normal) Test Result Varices Present Ratio<909 Varices Absent Ratio>909 Varices Present (Disease) a(61) True Positive Present Ratio<909 c(7) False Negative Present Ratio>909 Endoscopic Findings Varices Absent (No Disease) b(5) False Positive Absent Ratio<909 d(22) True Negative Absent Ratio>909 Total a+b(66) c+d(29) Total a+c(68) b+d(27) a+b+c+d(95) known as true positive rate) of platelet count to spleen diameter ratio (considering >909 as normal) as a predictor of esophageal varices in patients of liver cirrhosis due to Hepatitis C virus taking upper gastrointestinal tract endoscopy as gold standard was found to be 89.70%. Calculated specificity (also known as true negative rate) is 81.48%. Positive predictive value is 92.42% and negative predictive value was found to be 75.86%. DISCUSSION In this study all the patients who have developed esophageal varices have lower value of platelet count to spleen diameter ratio than those who have not developed esophageal varices yet. Other studies show comparable results in this regard also. Giannini E, Botta, Borro et al. 6 (Genova, Italy) conducted a study in which average platelet JUMDC Vol. 3, Issue 1, Jan-Jun 2012 9

count to spleen diameter ratio in patients who have not developed esophageal varices was 1638 and average platelet count to spleen diameter ratio in patients who have developed esophageal varices was 533. Similarly average platelet count to spleen diameter ratio in patients who have not developed esophageal varices was 2408.7 and average platelet count to spleen diameter ratio in patients who have developed esophageal varices was 862.6 in the study by Legasto GMA et al. 8 (Philippines). Average platelet count to spleen diameter ratio in patients who have not developed esophageal varices was 1107 and average platelet count to spleen diameter ratio in patients who have developed esophageal varices was 558 in the study by Giannini EG et al. 9 (Padua, Italy). So these results are similar to present study. When the cut off value of platelet count/spleen diameter ratio of 909 was used by Giannini E et al. 6 in Genova Italy, to predict the presence of esophageal varices the sensitivity was 100% specificity was 93%. Positive and negative predictive values for a platelet count/spleen diameter ratio <909 were 96% and 100%, respectively. Diagnostic accuracy of this platelet count/spleen diameter ratio with a cut off value of 909 was 98%. In the present study at medical wards of Allied Hospital, Faisalabad, sensitivity is 89.70%, specificity is 81.48%, positive predictive value is 92.42% and negative predictive value is 75.86%. In all these figures obtained from present study cut off value of platelet count/spleen diameter ratio for the presence of esophageal varices was 909. Platelet count/splenic diameter in centimeters ratio >909 was considered normal. Diagnostic accuracy of this platelet count/spleen diameter ratio with a cut off value of 909 is 87.36% in present study. All the results are slightly different from the study by Giannini E et al. 6 which may be due difference in sample size, human error in identifying esophageal varices during endoscopy, geographical difference and ethnicity difference of sample population studied and patients selected were only those who had cirrhosis secondary to hepatitis C virus as Giannini E et al. 6 selected patients for study who were affected by any virus. Sarwar S et al. 7 at Shaikh Zayed Medical Complex Lahore, found sensitivity and specificity of platelet count/splenic diameter in centimeters ratio to predict esophageal varices with a cut off value of 909 to be 13% and 77% respectively, which is far from significant. The results of Sarwar S et al. 7 differ from this present study as well as with Giannini E et al. 6. If patients can be identified with this noninvasive means they can be provided with primary prophylaxis, so fewer patients bleed and financial resources can be saved. Platelet count to spleen diameter ratio (with a cut off level of 909 to separate two groups of patients on the basis of presence of varices) can be achieved with no additional cost as most physicians usually carry out complete blood count and abdominal ultrasonography of these patients. CONCLUSION Platelet count to spleen diameter ratio (considering >909 as normal) has good diagnostic accuracy in identifying cases with esophageal varices. This test is cheap with no additional cost and can be done at a primary health care facility. REFERENCES 1. Burroughs AK and Westaby D. Liver, biliary tract and pancreatic disease. In: Kumar PJ, Clark ML, editors. Clinical Medicine. 5th ed. Edinburgh: W.B. Saunders, 2002:335-404. 2. Sharara AI, Hunt CM and Hamilton JD. Hepatitis C. Ann Intern Med. 1996; 125: 658-68. 3. Gratch D, Bacchi CE, Corey L, Delaroza C, Lesniewski RR, Kowdley K et al. Persistent Hepatitis C Virus Infection after Liver Transplantation: Clinical and Virological Features. Hepatology 1995; 22: 1-9. 4. Farooq MA, Iqbal MA, Tariq WZ, Hussain AB and Ghani I. Prevalence of Hepatitis B and C in Healthy Pakistani Adults. Pak J Pathol 2005; 16: 42-46. 10 JUMDC Vol. 3, Issue 1, Jan-Jun 2012

5. Kuntz E and Kuntz HD. Portal Hypertension. In: Hepatology principles and practice. 2 nd ed. Wurzburg: Springer Medizin Verlag, 2006: 243-60. 6. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of esophageal varices in patients with liver cirrhosis. Gut 2003; 52: 1200-05. 7. Sarwar S, Alam A, Khan AA, Butt AK, Shafqat F, Shah WH et al. Platelet count/splenic size ratio: Can it predict the presence of varices in patients of Cirrhosis of liver? Proceeding Shaikh Zayed Postgrad Med Inst 2004; 18: 21-6l. 8. Legasto GMA, Sevilla J, Balay A, Tan JA, Cham LV, Vitug A, et al. Platelet count/ spleen diameter ratio: A noninvasive parameter to predict the presence of esophageal varices. Phil J Gastroenterol 2006; 2: 33-38. 9. Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol. 2006; 101: 2511-9. Submitted for publication: 22-12-2011 Accepted for publication after minor revision} 26-03-2012 JUMDC Vol. 3, Issue 1, Jan-Jun 2012 11